Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
158 studies found for:    Open Studies | "Lupus Erythematosus, Systemic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Lupus Erythematosus, Systemic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Systemic Lupus Erythematous and Heart Conduction Disorders
Conditions: Lupus Erythematosus, Systemic;   Atrioventricular Block;   Sudden Death
Intervention: Other: No intervention
2 Not yet recruiting Using the Cholinergic Anit-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
Conditions: Lupus Erythematosus, Systemic;   Musculoskeletal Pain
Interventions: Device: Vagus nerve stimulation;   Device: Sham vagus nerve stimulation
3 Unknown  Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid
Intervention:
4 Recruiting MSC2364447C Phase 1b in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: MSC2364447C;   Drug: Placebo
5 Not yet recruiting Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)
Condition: Lupus Erythematosus, Systemic
Intervention: Other: Qi Gong
6 Unknown  Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Procedure: Hematopoietic Cell Transplantation
7 Unknown  Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
8 Not yet recruiting TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: TAB08;   Other: Placebo
9 Recruiting A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Biological: ALX-0061;   Biological: Placebo
10 Recruiting A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: IPP-201101;   Drug: Placebo;   Other: Standard of Care
11 Recruiting Safety and Effectiveness of Belimumab in Systemic Lupus Erythematosus Registry
Condition: Systemic Lupus Erythematosus
Interventions: Biological: BENLYSTA;   Other: SLE treatment
12 Recruiting Study of Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention:
13 Unknown  Mesenchymal Stem Cells Transplantation for Refractory Systemic Lupus Erythematosus (SLE)
Condition: Refractory Systemic Lupus Erythematosus
Intervention: Biological: Allogeneic MSC (AlloMSC)
14 Recruiting CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis
Condition: Systemic Lupus Erythematosus
Interventions: Drug: Blisibimod;   Drug: Placebo
15 Recruiting Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Condition: Active Systemic Lupus Erythematosus
Interventions: Biological: Anifrolumab;   Drug: Placebo
16 Recruiting Walk With Ease Program For Patients With Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus
Intervention: Other: "Walk With Ease"
17 Recruiting GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus
Condition: Systemic Lupus Erythematosus (SLE)
Intervention: Genetic: Blood sampling
18 Recruiting Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients
Condition: Systemic Lupus Erythematosus
Interventions: Drug: MT-1303 Low dose;   Drug: MT-1303 High dose
19 Recruiting Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)
Conditions: Systemic Lupus Erythematosus;   SLE
Interventions: Drug: Mycophenolate Mofetil;   Drug: Hydroxychloroquine or Chloroquine;   Drug: Prednisone
20 Unknown  Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus.
Conditions: Systemic Lupus Erythematosus;   Sleep Disorders
Interventions: Procedure: Aerobic Exercise;   Other: Control Group

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years